Total Payments
$5,626
2024 Payments
$905.86
Companies
23
Transactions
221
Medicare Patients
1,921
Medicare Billing
$105,942
Payment Breakdown by Category
Food & Beverage$5,314 (94.5%)
Education$194.98 (3.5%)
Other$116.26 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,314 | 217 | 94.5% |
| Education | $194.98 | 2 | 3.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $116.26 | 2 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,209 | 58 | $0 (2024) |
| Incyte Corporation | $855.53 | 27 | $0 (2024) |
| GENZYME CORPORATION | $455.72 | 16 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $404.35 | 16 | $0 (2024) |
| Lilly USA, LLC | $392.28 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $391.00 | 17 | $0 (2024) |
| Galderma Laboratories, L.P. | $341.03 | 14 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $254.89 | 16 | $0 (2024) |
| UCB, Inc. | $207.09 | 6 | $0 (2023) |
| PFIZER INC. | $156.06 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $905.86 | 33 | Incyte Corporation ($307.37) |
| 2023 | $1,341 | 62 | ABBVIE INC. ($397.19) |
| 2022 | $1,453 | 53 | ABBVIE INC. ($346.10) |
| 2021 | $1,926 | 73 | AbbVie Inc. ($407.86) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $97.19 | General |
| Category: Dermatology | ||||||
| 08/16/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $44.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/09/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $110.69 | General |
| Category: Dermatology | ||||||
| 05/17/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.56 | General |
| Category: Dermatology | ||||||
| 05/17/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $6.53 | General |
| Category: Dermatology | ||||||
| 05/17/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $0.28 | General |
| Category: Dermatology | ||||||
| 05/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.05 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: Dermatology | ||||||
| 05/06/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: DERMATOLOGY | ||||||
| 05/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Immunology | ||||||
| 04/29/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Dermatology | ||||||
| 04/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: Immunology | ||||||
| 04/15/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Dermatology | ||||||
| 04/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Dermatology | ||||||
| 04/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.58 | General |
| Category: Immunology | ||||||
| 03/29/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: Inflammation | ||||||
| 03/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: DERMATOLOGY | ||||||
| 03/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $34.16 | General |
| Category: Immunology | ||||||
| 03/18/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: DERMATOLOGY | ||||||
| 03/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $8.74 | General |
| Category: Dermatology | ||||||
| 03/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/26/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.75 | General |
| Category: Dermatology | ||||||
| 02/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: DERMATOLOGY | ||||||
| 02/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $6.84 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 685 | 1,090 | $129,002 | $44,482 |
| 2022 | 10 | 554 | 990 | $92,480 | $28,865 |
| 2021 | 8 | 418 | 715 | $74,238 | $21,382 |
| 2020 | 9 | 264 | 427 | $42,958 | $11,214 |
Total Patients
1,921
Total Services
3,222
Medicare Billing
$105,942
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 119 | $22,200 | $9,161 | 41.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 117 | 117 | $22,083 | $7,397 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 119 | $18,197 | $6,330 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $16,109 | $5,320 | 33.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 57 | 64 | $12,393 | $4,445 | 35.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 107 | 139 | $15,857 | $4,438 | 28.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 79 | 375 | $4,269 | $1,582 | 37.1% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 17 | 23 | $4,766 | $1,544 | 32.4% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 16 | 17 | $3,949 | $1,413 | 35.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 26 | 26 | $4,450 | $1,369 | 30.8% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 15 | 19 | $3,287 | $920.65 | 28.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 15 | $1,441 | $561.75 | 39.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 75 | 75 | $13,808 | $4,613 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $10,104 | $4,288 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 86 | $15,368 | $3,985 | 25.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 114 | 122 | $15,154 | $3,761 | 24.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 49 | 52 | $10,688 | $3,386 | 31.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 54 | 57 | $11,352 | $2,909 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 33 | $6,464 | $2,784 | 43.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 86 | 493 | $6,227 | $2,088 | 33.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 13 | 16 | $1,666 | $539.97 | 32.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 15 | $1,650 | $509.74 | 30.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 89 | $16,688 | $4,878 | 29.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 60 | 63 | $13,845 | $3,900 | 28.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 50 | 50 | $11,506 | $3,225 | 28.0% |
About Daniel Green
Daniel Green is a Physician Assistant healthcare provider based in Fayetteville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/18/2014. The National Provider Identifier (NPI) number assigned to this provider is 1700288966.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Green has received a total of $5,626 in payments from pharmaceutical and medical device companies, with $905.86 received in 2024. These payments were reported across 221 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($5,314).
As a Medicare-enrolled provider, Green has provided services to 1,921 Medicare beneficiaries, totaling 3,222 services with total Medicare billing of $105,942. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Fayetteville, NY
- Active Since 09/18/2014
- Last Updated 09/18/2014
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1700288966
Products in Payments
- SKYRIZI (Biological) $865.97
- OPZELURA (Drug) $742.91
- DUPIXENT (Biological) $490.94
- TALTZ (Drug) $310.18
- RINVOQ (Biological) $255.66
- TREMFYA (Drug) $235.93
- AKLIEF (Drug) $205.17
- COSENTYX (Drug) $157.16
- REMICADE (Biological) $155.07
- NEXLETOL (Drug) $150.00
- AMZEEQ (Drug) $129.11
- CIBINQO (Drug) $127.83
- WYNZORA (Drug) $100.00
- TWYNEO (Drug) $97.86
- ILUMYA (Biological) $97.59
- ADBRY (Biological) $95.75
- VTAMA (Drug) $90.70
- HUMIRA (Biological) $87.19
- Cimzia (Drug) $85.81
- Otezla (Drug) $71.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Fayetteville
Peter Kalogerinis, Pa-C, PA-C
Physician Assistant — Payments: $72,155
Physician Assistant $72,155
William Davis
Physician Assistant — Payments: $9,192
Physician Assistant $9,192
Mr. William Cotton, Pa-C, PA-C
Physician Assistant — Payments: $6,861
Physician Assistant $6,861
Emily Townsend, Pa-C, PA-C
Physician Assistant — Payments: $6,735
Physician Assistant $6,735
Thomas Daignault, Pa, PA
Physician Assistant — Payments: $5,954
Physician Assistant $5,954
Mr. Joshua Matthews, Pa-C, PA-C
Physician Assistant — Payments: $5,342
Physician Assistant $5,342